antibiotic
therapy
cystic
fibrosis
increased
resistance
mucoid
pseudomonas
aeruginosa
carbenicillin
present
communication
reports
effect
bacterial
mucus
activity
antibodies
strains
p
aeruginosa
mucoid
variants
p
aeruginosa
obtained
non
mucoid
strains
pao
pat
selection
phenotypic
resistance
virulent
phage
e
resistant
carbenicillin
non
mucoid
parent
strains
mucoid
p
aeruginosa
strains
isolated
two
cf
patients
resistant
carbenicillin
non
mucoid
strains
isolated
samples
sputum
experiments
already
described
repeated
oxytetracycline
contrast
experience
carbenicillin
mucoid
strains
found
sensitive
non
mucoid
strains
prove
hypothesis
mucoid
strains
selected
vivo
carbenicillin
therapy
necessary
show
level
carbenicillin
cf
secretions
less
minimum
inhibitory
concentrations
mucoid
strains
greater
non
mucoid
strains
investigating
additional
cf
isolates
conjunction
range
antibiotics
used
chemotherapy
cf
patients
